Israeli company FlowSense Medical, which develops urine monitoring systems, has been acquired by healthcare company Baxter International for $9.5 million. The acquisition was announced by the Trendlines Group, of which FlowSense is a portfolio company.
FlowSense, founded in 2009 by TrendLines, is the developer of the URINFO fluid monitoring system, which provides accurate, real-time, and continuous monitoring of urine output.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments